Task: Answer the multiple choice question.
Query: Which drug exhibits a 13.631% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1ccc(-c2csc(Nc3cc(C)ccn3)n2)cc1OC
[b] CS(=O)(=O)N(CC(=O)N1CCN(Cc2ccccc2)CC1)c1cccc([N+](=O)[O-])c1
Answer: a. COc1ccc(-c2csc(Nc3cc(C)ccn3)n2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-c2csc(Nc3cc(C)ccn3)n2)cc1OC
COc1ccc(-c2csc(Nc3cc(C)ccn3)n2)cc1OC
4-(3,4-dimethoxyphenyl)-N-(4-methylpyridin-2-yl)-1,3-thiazol-2-amine